Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase NA 2Phase 3 2Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2

Interventions

Exercise 440Blood Specimen Collection 335Standard of Care 325Magnetic Resonance Spectroscopy 260Radiotherapy 255Surveys and Questionnaires 246Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 146Surgical Procedures, Operative 136Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 111Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 83Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × trioctyl phosphine oxide × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

NCT00618813 2014-09-25

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Children's Oncology Group

Phase NA Completed
35 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡